Delivery Order SPE2DB22D3011-SPE2DB22FP9JT
Award Date
9/20/22
Potential Completion Date
9/21/22
Potential Value
$108K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $143,356.00 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was not...
This is a $4,934.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products, with a performance period ending on January 25, 2024. This delivery order is part of Amerisourcebergen Drug Corp's prime contract with DLA to provide...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563276138 MENQUADFI VIAL 0.5ML. The potential value of the contract is $1,404.96. This delivery order was issued under Amerisourcebergen's existing contract to provide pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities. Amerisourcebergen has a history of supporting DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,756.20 order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award does not have a set-aside designation and the place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is an experienced...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Amerisourcebergen Corporation. The contract, which has a potential value of $11,427.60, is for the provision of MENQUADFI VIAL 0.5ML pharmaceuticals. The award was made on a firm fixed price basis, with a performance location at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. No set-aside designations were used...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,391.76 to supply 4562597830 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by October 26, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,404.96 contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of February 1, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,809.92, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to Conshohocken, Pennsylvania. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and has previously held other indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The award, valued at $7,024.80, is a firm-fixed price delivery order that has an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no indication of any subcontractors. This delivery order is likely part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a firm fixed price of $59,794.56 and a completion date of January 12, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp has...